Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab.
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
8
References
2
Citations
NaN
KQI